Leukemia Clinical Trials

Showing 2901-2920 of 5,235 trials

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

NCT04746092

The corona pandemic is a continuing global challenge due to Corona Virus 2019 (COVID-19). The purpose of the study is to evaluate the capability of Haemato-oncology patients to generate antibodies against COVID-19 after infection and vaccination.

CLLMultiple MyelomaLymphoma

Tel-Aviv Sourasky Medical Center630 participantsStarted Jan 2021

Tel Aviv, Israel

COMPLETED

DCB Angioplasty for Coronary Lesions: an OCT Analysis

NCT04984135

In this study, the investigators preformed OCT before and after DCB treatment, as well as at 6 months of follow-up, to assess the tissue characterization. The aim of this study was to investigate the relationship between quantitative and qualitative OCT findings, angiographic and clinical outcomes after PCB for coronary lesions.

Coronary StenosisDrug-coated Balloon

The First Affiliated Hospital of Dalian Medical University70 participantsStarted Dec 2020

Dalian, Liaoning, China

Approved For Marketing

Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

NCT04204928

This is a global, multicenter, open-label pre-approval access program to provide access to pralsetinib (BLU-667) until such time that pralsetinib becomes available through other mechanisms or the Sponsor chooses to discontinue the program.

Non-Small Cell Lung CancerMedullary Thyroid Cancer

Blueprint Medicines Corporation

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

DCB Angioplasty for Coronary Lesions: an OCT Analysis

Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

Related Searches

A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Chronic Postsurgical Pediatric Pain. Evaluation Risk Factors to Develop Chronic Postsurgical Pain in Children and Adolescents Undergoing Surgery in a First Level Hospital

Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia

Improving Capacity to Reduce Fall-Related Injury Risk in Older Adults

Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation

PVI for TVC Response

Delayed Small-Bowel Anastomosis in Patients With Postoperative Peritonitis

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer